Jenner & Block represented the Legal Council for Health Justice in its successful effort to end Illinois' policy of rationing Medicaid participants’ coverage of life-saving drugs to cure hepatitis C (HCV).
The deadliest infectious disease in the United States, HCV affects an estimated 3.5 million Americans, including 68,400 Illinoisans. Previously, individuals enrolled in Medicaid were required to have severe liver damage before receiving coverage for treatment that would cure them of HCV. Additionally, some Medicaid participants were required to provide proof of sobriety for six months.
In October 2018, Jenner & Block joined the Legal Council for Health Justice and the Center for Health Law and Policy Innovation at Harvard Law School in sending a formal demand letter to Illinois officials on behalf of Medicaid participants.
On November 7, 2018, the Illinois Department of Health and Family Services announced it would change its policy. Now, a recognized HCV cure – direct acting antivirals, or DAAs – is accessible to thousands of Illinoisans, many of whom were previously denied treatment until they reached end-stage disease.